Can Globus Medical Inc’s (GMED) drop of -1.29% in a week be considered a lucky break?

On Tuesday, Globus Medical Inc (NYSE: GMED) opened lower -2.61% from the last session, before settling in for the closing price of $57.37. Price fluctuations for GMED have ranged from $54.48 to $94.93 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

A company in the Healthcare sector has dropped its sales by -13.26% annually for the last half of the decade. Company’s average yearly earnings per share was noted 0.80% at the time writing. With a float of $112.29 million, this company’s outstanding shares have now reached $112.93 million.

In an organization with 5300 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 57.02%, operating margin of 10.73%, and the pretax margin is 9.28%.

Globus Medical Inc (GMED) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Globus Medical Inc is 17.06%, while institutional ownership is 82.40%. The most recent insider transaction that took place on Feb 28 ’25, was worth 590,100. In this transaction Director of this company sold 7,500 shares at a rate of $78.68, taking the stock ownership to the 35,384 shares. Before that another transaction happened on Feb 28 ’25, when Company’s Director proposed sale 7,500 for $78.67, making the entire transaction worth $590,000.

Globus Medical Inc (GMED) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around 0.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.71% during the next five years compared to -13.26% drop over the previous five years of trading.

Globus Medical Inc (NYSE: GMED) Trading Performance Indicators

Check out the current performance indicators for Globus Medical Inc (GMED). In the past quarter, the stock posted a quick ratio of 2.72. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.01. Likewise, its price to free cash flow for the trailing twelve months is 14.47.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.34, a number that is poised to hit 0.76 in the next quarter and is forecasted to reach 3.66 in one year’s time.

Technical Analysis of Globus Medical Inc (GMED)

Let’s dig in a bit further. During the last 5-days, its volume was 1.52 million. That was better than the volume of 1.42 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 22.21%.

During the past 100 days, Globus Medical Inc’s (GMED) raw stochastic average was set at 4.62%, which indicates a significant decrease from 6.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.54 in the past 14 days, which was lower than the 1.98 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $60.09, while its 200-day Moving Average is $74.36. However, in the short run, Globus Medical Inc’s stock first resistance to watch stands at $57.30. Second resistance stands at $58.72. The third major resistance level sits at $59.53. If the price goes on to break the first support level at $55.07, it is likely to go to the next support level at $54.26. The third support level lies at $52.84 if the price breaches the second support level.

Globus Medical Inc (NYSE: GMED) Key Stats

There are currently 135,379K shares outstanding in the company with a market cap of 7.56 billion. Presently, the company’s annual sales total 2,519 M according to its annual income of 102,980 K. Last quarter, the company’s sales amounted to 598,120 K and its income totaled 75,460 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.